"Myocardial survival signaling in response to stem cell transplantation."
Osiris Therapeutics had something going on in this respect. We're talking "too late," and "too far gone," not prevention.
Wednesday, June 3, 2009
Some work I did on Mesenchymal Stem Cell Therapy on the Infarcted Myocardium
Labels:
Advancing Medicine,
Cardiology,
Heart Attack,
JACS,
John Cha Science
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment